HR Execs on the Move

Omega Protein

www.omegaprotein.com

 
Omega Protein Corporation was a publicly traded US company, founded in 1913 as a fishing operation.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Vanda Pharmaceuticals

Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs. The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.

Codman Square Health Center

The mission of Codman Square Health Center is to serve as a resource for improving the physical, mental and social well-being of the community. Codman Square Health Center is an award-winning, community-based, outpatient health care and multi-service center in the heart of Dorchester. We opened our doors in 1979 with a dream: to build the best urban community in America. With a holistic and partnership-oriented approach, we ensure access to quality health care and other supportive services through a highly successful integrated model.

Excelsior Wellness

Excelsior Wellness is a nonprofit corporation supporting multiple organizations connected through a common purpose. We connect children, adults and families to their futures by empowering them to live healthy, stronger, and more satisfying lives. We accomplish this by providing quality programs holistically rooted in the eight dimensions of wellness.

one45 Software

one45 Software Inc. is a Creston, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.